Orchid Pharma (ORCHPHARMA.BO) Earnings Analysis
Orchid Pharma (ORCHPHARMA.BO) next reports earnings on 2026-08-06, consensus EPS 3.6 INR. Last quarter (2026-05-25) it beat with EPS 4.7 INR vs 3 INR est (+56.7%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E 238.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ORCHPHARMA.BO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 3.6 INR |
| Revenue estimate | 2.31B |
ORCHPHARMA.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-25 | 4.7 INR | 3 INR | +56.7% | Beat |
| 2026-02-11 | 4.1 INR | -0.3 INR | +1466.7% | Beat |
| 2025-08-12 | 2.9 INR | 3.7 INR | -21.6% | Miss |
| 2025-05-26 | 4.4 INR | 4.4 INR | 0% | Beat |
| 2025-02-12 | 4.25 INR | 6.3 INR | -32.5% | Miss |
| 2024-11-11 | 5.4 INR | 4 INR | +35% | Beat |
| 2024-08-12 | 5.8 INR | 6.9 INR | -15.9% | Miss |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
ORCHPHARMA.BO valuation and analyst view
| Trailing P/E | 238.98 |
|---|---|
| Trailing EPS | 4.014 INR |
| Price / book | 3.77 |
| Dividend yield | 0.00% |
| Market cap | 50.89B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Orchid Pharma (ORCHPHARMA.BO)'s next earnings date?
Orchid Pharma is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 3.6 INR and revenue estimate of 2.31B.
Did ORCHPHARMA.BO beat earnings last quarter?
In its 2026-05-25 report, ORCHPHARMA.BO posted EPS of 4.7 INR versus a 3 INR estimate — a beat of 56.7%.
What is ORCHPHARMA.BO's earnings track record?
Over the last 7 reported quarters with consensus data, ORCHPHARMA.BO beat estimates 4 times (57%).
What is ORCHPHARMA.BO's current P/E ratio and EPS?
ORCHPHARMA.BO trades at a trailing P/E of 238.98 on trailing EPS of 4.014219785421268 INR.
What do analysts rate ORCHPHARMA.BO?
ORCHPHARMA.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.